These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10209295)

  • 1. The role of the P2' position of Bowman-Birk proteinase inhibitor in the inhibition of trypsin. Studies on P2' variation in cyclic peptides encompassing the reactive site loop.
    Gariani T; McBride JD; Leatherbarrow RJ
    Biochim Biophys Acta; 1999 Apr; 1431(1):232-7. PubMed ID: 10209295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of protease inhibitors based on the Bowman-Birk reactive site loop to hydrolysis by proteases.
    Gariani T; Leatherbarrow RJ
    J Pept Res; 1997 Jun; 49(6):467-75. PubMed ID: 9266473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of threonine in the P2 position of Bowman-Birk proteinase inhibitors: studies on P2 variation in cyclic peptides encompassing the reactive site loop.
    McBride JD; Brauer AB; Nievo M; Leatherbarrow RJ
    J Mol Biol; 1998 Sep; 282(2):447-58. PubMed ID: 9735299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a mixture of cyclic peptides based on the Bowman-Birk reactive site loop to screen for serine protease inhibitors.
    Domingo GJ; Leatherbarrow RJ; Freeman N; Patel S; Weir M
    Int J Pept Protein Res; 1995 Jul; 46(1):79-87. PubMed ID: 7558601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peptide mimics of the Bowman-Birk inhibitor protein.
    McBride JD; Leatherbarrow RJ
    Curr Med Chem; 2001 Jul; 8(8):909-17. PubMed ID: 11375759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of chymotrypsin inhibitors from a conformationally-constrained combinatorial peptide library.
    McBride JD; Freeman N; Domingo GJ; Leatherbarrow RJ
    J Mol Biol; 1996 Jun; 259(4):819-27. PubMed ID: 8683585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The conserved P1' Ser of Bowman-Birk-type proteinase inhibitors is not essential for the integrity of the reactive site loop.
    Brauer AB; Leatherbarrow RJ
    Biochem Biophys Res Commun; 2003 Aug; 308(2):300-5. PubMed ID: 12901868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birk inhibitor.
    Bueno NR; Fritz H; Auerswald EA; Mentele R; Sampaio M; Sampaio CA; Oliva ML
    Biochem Biophys Res Commun; 1999 Aug; 261(3):838-43. PubMed ID: 10441512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
    Weder JK; Hinkers SC
    J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide mimics of the Bowman-Birk inhibitor reactive site loop.
    McBride JD; Watson EM; Brauer AB; Jaulent AM; Leatherbarrow RJ
    Biopolymers; 2002; 66(2):79-92. PubMed ID: 12325158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the synthesis of proteinase inhibitors. II. Synthesis of cyclic nonapeptide fragments and analogs related to the reactive sites of soybean Bowman-Birk inhibitor.
    Terada S; Sato K; Kato T; Izumiya N
    Int J Pept Protein Res; 1980 May; 15(5):441-54. PubMed ID: 7440053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On a Bowman-Birk family proteinase inhibitor from Erythrina variegata seeds.
    Kimura M; Kouzuma Y; Abe K; Yamasaki N
    J Biochem; 1994 Mar; 115(3):369-72. PubMed ID: 8056744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and analysis of novel bicyclic and bifunctional protease inhibitors.
    Jaulent AM; Leatherbarrow RJ
    Protein Eng Des Sel; 2004 Sep; 17(9):681-7. PubMed ID: 15486024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The (1)H-NMR solution structure of the antitryptic core peptide of Bowman-Birk inhibitor proteins: a minimal canonical loop.
    Brauer AB; Kelly G; Matthews SJ; Leatherbarrow RJ
    J Biomol Struct Dyn; 2002 Aug; 20(1):59-70. PubMed ID: 12144352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
    Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
    Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive sites of an anticarcinogenic Bowman-Birk proteinase inhibitor are similar to other trypsin inhibitors.
    Chen P; Rose J; Love R; Wei CH; Wang BC
    J Biol Chem; 1992 Jan; 267(3):1990-4. PubMed ID: 1730730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of chymotrypsin inhibitors from a second-generation template assisted combinatorial peptide library.
    McBride JD; Freeman HN; Leatherbarrow RJ
    J Pept Sci; 2000 Sep; 6(9):446-52. PubMed ID: 11016881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and bio-assay of RCM-derived Bowman-Birk inhibitor analogues.
    Miles SM; Leatherbarrow RJ; Marsden SP; Coates WJ
    Org Biomol Chem; 2004 Feb; 2(3):281-3. PubMed ID: 14747852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the synthesis of proteinase inhibitors. I. Synthesis and activity of nonapeptide fragments of soybean Bowman-Birk inhibitor.
    Nishino N; Aoyagi H; Kato T; Izumiya N
    J Biochem; 1977 Sep; 82(3):901-9. PubMed ID: 914812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Target-Modification of SL-BBI: A Novel Bowman-Birk Type Trypsin Inhibitor from
    Chen X; Chen D; Huang L; Chen X; Zhou M; Xi X; Ma C; Chen T; Wang L
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32872343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.